What is BDQ?: Understanding Bedaquiline in Tuberculosis Treatment
•
5 min read
As of 2024, approximately half a million people globally are estimated to become ill with multidrug-resistant or rifampicin-resistant tuberculosis annually. This public health crisis has made the development of novel treatments critical, leading to the introduction of BDQ, or bedaquiline, a medication used to combat these stubborn infections.
